-
Most Recent
Search Results
240 results for XON
Earnings Season Just Proved the AI Economy Is Splitting in Two
The companies building, powering, connecting, and computing for the AI era are operating in an environment of structurally constrained supply against structurally growing demand… the…
The Biggest Myth In the Market Just Broke
The rally in AI stocks isn’t broadening — it’s concentrating. New data shows capital flowing into fewer winners across semiconductors and infrastructure.
Is the $725 Billion AI Spending Boom Paying Off?
Big Tech is spending $725 billion on the artificial intelligence buildout. And that’s just this year. That’s why all eyes have been glued to the…
This 150% Run Is Just the Beginning
The AI trade shifts to CPUs… Luke Lango with a batch of AI stocks to consider… Jonathan Rose eyes a Canadian oil squeeze … Louis…
Why Great Earnings Don’t Always Boost Prices
Progress in the Middle East unravels over the weekend… TSMC’s perfect earnings report fizzles… great reports from the banks go nowhere… how to trade this…
The AI Nobody’s Talking About Is Already Picking Winners
To understand why Mythos matters, you need to understand what’s been building underneath it. A new kind of AI that doesn’t just respond to prompts……
Why Intrexon, LendingClub and CA Technologies Are 3 of Today’s Worst Stocks
Intrexon Corp., LendingClub Corporation and CA Technologies, Inc. used more than their fair share of red ink on Wednesday. Here’s the deal.
Apple Reaches Value of Entire 1977 Market
We knew Apple was big, but gains today make its value equal to that of the entire market more than 30 years ago. That’s just…
4 Biotechnology Stocks to Sell Now
This week, the ratings of four biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
OpenAI Is Building What Comes After the iPhone
OpenAI and Qualcomm are building an AI-first device — signaling the shift beyond smartphones and reshaping tech’s next winners.
6 Biotechnology Stocks to Buy Now
Six biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
The Software Crash That’s Creating the Next 1,000% Winners
Mythos isn’t just a better chatbot; it’s a signal that AI has crossed an important threshold, moving from a tool that responds to instructions… to…
8 Biotechnology Stocks to Buy Now
The grades of 8 Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…
12 Stocks to Buy After Meta’s Deal to Beam Energy From Space
The core insight behind what we call the Orbital Compute thesis is elegantly simple: Terrestrial infrastructure is resource-bound. Orbital infrastructure is technology-bound.
Copper’s Mixed Signals Are Your Next Big Opportunity
Let’s make Dr. Copper our patient today and examine its recent movements. After all, demand-driven and supply-driven spikes lead to very different outcomes for investors.…
War, Watts, and the AI Buildout That Won’t Stop
On this week’s Being Exponential, Luke connects the dots between the Iran blockade, orbital compute, prediction markets, and the biggest headwind facing AI stocks right…
11 Biotechnology Stocks to Buy Now
This week, 11 biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B”…
Gold or Silver – Which Do You Buy Right Now?
The gold-to-silver ratio resets to equilibrium… Luke’s case for a silver melt-up… Eric’s case for gold… the fiscal disorder fueling the longer-term bet… so, which…
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
How to Read a Stock’s ‘Behavioral Profile’
Discover how behavioral stock analysis patterns reveal the hidden ‘tells’ behind big moves – and the AI system mapping them now.
Why GameStop, U.S. Silica, and Ziopharm are 3 of Today’s Best Stocks
Poor December retail sales, a Fed warning on slower growth, and a copper meltdown spooks Wall Street, but Gamestop, U.S. Silica, and Ziopharm are three…
Diversification Can’t Protect Exxon Stock in Oil Price Plunge (XOM)
Even Exxon Mobil Corporation’s refining and marketing business — which benefits from lower oil prices — let XOM down in the fourth quarter.
6 – 10 of 240 results
